ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 124 filers reported holding ARBUTUS BIOPHARMA CORP in Q4 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $282,111 | -2.4% | 138,971 | +10.5% | 0.00% | – |
| Q2 2023 | $289,181 | +126.1% | 125,731 | +197.9% | 0.00% | – |
| Q1 2023 | $127,890 | +30.0% | 42,208 | 0.0% | 0.00% | – |
| Q4 2022 | $98,345 | +22.0% | 42,208 | 0.0% | 0.00% | – |
| Q3 2022 | $80,617 | -29.3% | 42,208 | 0.0% | 0.00% | – |
| Q2 2022 | $114,000 | +23.9% | 42,208 | +36.4% | 0.00% | – |
| Q1 2022 | $92,000 | -23.3% | 30,937 | 0.0% | 0.00% | – |
| Q4 2021 | $120,000 | -12.4% | 30,937 | -2.8% | 0.00% | – |
| Q3 2021 | $137,000 | +42.7% | 31,842 | 0.0% | 0.00% | – |
| Q2 2021 | $96,000 | +100.0% | 31,842 | +137.6% | 0.00% | – |
| Q1 2019 | $48,000 | -5.9% | 13,404 | 0.0% | 0.00% | – |
| Q4 2018 | $51,000 | -59.8% | 13,404 | 0.0% | 0.00% | – |
| Q3 2018 | $127,000 | +29.6% | 13,404 | 0.0% | 0.00% | – |
| Q2 2018 | $98,000 | – | 13,404 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 3,705,128 | $10,300,000 | 4.44% |
| RTW INVESTMENTS, LP | 5,666,754 | $15,754,000 | 0.59% |
| COWEN AND COMPANY, LLC | 926,200 | $2,575,000 | 0.22% |
| Hudson Bay Capital Management LP | 850,000 | $2,363,000 | 0.05% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 1,774,915 | $4,934,000 | 0.03% |
| Point72 Asset Management, L.P. | 1,897,284 | $5,274,000 | 0.03% |
| 683 Capital Management, LLC | 77,368 | $215,000 | 0.02% |
| Secure Asset Management, LLC | 10,000 | $28,000 | 0.02% |
| Qube Research & Technologies Ltd | 166,138 | $462,000 | 0.01% |
| Verition Fund Management LLC | 174,455 | $485,000 | 0.01% |